BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 38418620)

  • 1. The therapeutic effect of mesenchymal stem cells in diabetic kidney disease.
    Habiba UE; Khan N; Greene DL; Shamim S; Umer A
    J Mol Med (Berl); 2024 Apr; 102(4):537-570. PubMed ID: 38418620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Promise of Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease.
    Griffin TP; Martin WP; Islam N; O'Brien T; Griffin MD
    Curr Diab Rep; 2016 May; 16(5):42. PubMed ID: 27007719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic role of mesenchymal stem cells (MSCs) in diabetic kidney disease (DKD).
    Xu N; Liu J; Li X
    Endocr J; 2022 Oct; 69(10):1159-1172. PubMed ID: 35858781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic kidney disease induces transcriptome alterations associated with angiogenesis activity in human mesenchymal stromal cells.
    Bian X; Conley SM; Eirin A; Zimmerman Zuckerman EA; Smith AL; Gowan CC; Snow ZK; Jarmi T; Farres H; Erben YM; Hakaim AG; Dietz MA; Zubair AC; Wyles SP; Wolfram JV; Lerman LO; Hickson LJ
    Stem Cell Res Ther; 2023 Mar; 14(1):49. PubMed ID: 36949528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of mesenchymal stem cells in diabetic kidney disease: mechanisms, signaling pathways, and preclinical evidence.
    Zhu Y; Luo M; Bai X; Lou Y; Nie P; Jiang S; Li J; Li B; Luo P
    Mol Cell Biochem; 2022 Aug; 477(8):2073-2092. PubMed ID: 35469057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Potential of Mesenchymal Stem Cells in a Pre-Clinical Model of Diabetic Kidney Disease and Obesity.
    Sávio-Silva C; Soinski-Sousa PE; Simplício-Filho A; Bastos RMC; Beyerstedt S; Rangel ÉB
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of mesenchymal stem cells in diabetic kidney disease: a systematic review and meta-analysis.
    Lin W; Li HY; Yang Q; Chen G; Lin S; Liao C; Zhou T
    Stem Cell Res Ther; 2021 Jan; 12(1):43. PubMed ID: 33413678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of the efficacy and signaling pathways activated by stem cell-derived extracellular vesicles in diabetic kidney disease.
    Lin Y; Yang Q; Wang J; Chen X; Liu Y; Zhou T
    Front Endocrinol (Lausanne); 2022; 13():962635. PubMed ID: 35966088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paracrine effect of mesenchymal stem cell as a novel therapeutic strategy for diabetic nephropathy.
    Li H; Rong P; Ma X; Nie W; Chen C; Yang C; Zhang J; Dong Q; Wang W
    Life Sci; 2018 Dec; 215():113-118. PubMed ID: 30399376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review and meta-analysis of cell-based interventions in experimental diabetic kidney disease.
    Hickson LJ; Abedalqader T; Ben-Bernard G; Mondy JM; Bian X; Conley SM; Zhu X; Herrmann SM; Kukla A; Lorenz EC; Kim SR; Thorsteinsdottir B; Lerman LO; Murad MH
    Stem Cells Transl Med; 2021 Sep; 10(9):1304-1319. PubMed ID: 34106528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Multi-Therapeutic Role of MSCs in Diabetic Nephropathy.
    Wang Y; Shan SK; Guo B; Li F; Zheng MH; Lei LM; Xu QS; Ullah MHE; Xu F; Lin X; Yuan LQ
    Front Endocrinol (Lausanne); 2021; 12():671566. PubMed ID: 34163437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Placental Mesenchymal Stem Cells with Guided Nanoparticles Effective Against Diabetic Nephropathy in Mouse Model.
    Wang K; Liu T; Zhang Y; Lv H; Yao H; Zhao Y; Li J; Li X
    Int J Nanomedicine; 2024; 19():901-915. PubMed ID: 38293609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal Stem Cell-Derived Exosomes Ameliorate Diabetic Kidney Disease Through the NLRP3 Signaling Pathway.
    Wang Y; Liu J; Wang H; Lv S; Liu Q; Li S; Yang X; Liu G
    Stem Cells; 2023 Apr; 41(4):368-383. PubMed ID: 36682034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental Mesenchymal Stem Cells Alleviate Podocyte Injury in Diabetic Kidney Disease by Modulating Mitophagy via the SIRT1-PGC-1alpha-TFAM Pathway.
    Han X; Wang J; Li R; Huang M; Yue G; Guan L; Deng Y; Cai W; Xu J
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress toward the Clinical Application of Mesenchymal Stromal Cells and Other Disease-Modulating Regenerative Therapies: Examples from the Field of Nephrology.
    Hickson LJ; Herrmann SM; McNicholas BA; Griffin MD
    Kidney360; 2021 Mar; 2(3):542-557. PubMed ID: 34316720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic Kidney Disease Alters the Transcriptome and Function of Human Adipose-Derived Mesenchymal Stromal Cells but Maintains Immunomodulatory and Paracrine Activities Important for Renal Repair.
    Hickson LJ; Eirin A; Conley SM; Taner T; Bian X; Saad A; Herrmann SM; Mehta RA; McKenzie TJ; Kellogg TA; Kirkland JL; Tchkonia T; Saadiq IM; Tang H; Jordan KL; Zhu X; Griffin MD; Rule AD; van Wijnen AJ; Textor SC; Lerman LO
    Diabetes; 2021 Jul; 70(7):1561-1574. PubMed ID: 33858824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human placenta-derived mesenchymal stem cells ameliorate diabetic kidney disease by modulating the T helper 17 cell/ regulatory T-cell balance through the programmed death 1 / programmed death-ligand 1 pathway.
    Wang J; Liu H; Yue G; Deng Y; Cai W; Xu J
    Diabetes Obes Metab; 2024 Jan; 26(1):32-45. PubMed ID: 37722965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intervention for early diabetic nephropathy by mesenchymal stem cells in a preclinical nonhuman primate model.
    An X; Liao G; Chen Y; Luo A; Liu J; Yuan Y; Li L; Yang L; Wang H; Liu F; Yang G; Yi S; Li Y; Cheng J; Lu Y
    Stem Cell Res Ther; 2019 Dec; 10(1):363. PubMed ID: 31791397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-146a-5p-modified human umbilical cord mesenchymal stem cells enhance protection against diabetic nephropathy in rats through facilitating M2 macrophage polarization.
    Zhang Y; Le X; Zheng S; Zhang K; He J; Liu M; Tu C; Rao W; Du H; Ouyang Y; Li C; Wu D
    Stem Cell Res Ther; 2022 Apr; 13(1):171. PubMed ID: 35477552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placenta-derived mesenchymal stem cells protect against diabetic kidney disease by upregulating autophagy-mediated SIRT1/FOXO1 pathway.
    Liu H; Wang J; Yue G; Xu J
    Ren Fail; 2024 Dec; 46(1):2303396. PubMed ID: 38234193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.